Auxier Asset Management’s Quest Diagnostics DGX Stock Holding History

Auxier Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.99M	Sell	25,451 -460	-2%	-$89.4K	0.72%	43
2025 Q4	$4.5M	Sell	25,911 -387	-1%	-$70.5K	0.63%	44
2025 Q3	$5.01M	Sell	26,298 -479	-2%	-$85K	0.7%	42
2025 Q2	$4.81M	Sell	26,777 -125	-0.5%	-$21.7K	0.71%	44
2025 Q1	$4.55M	Sell	26,902 -675	-2%	-$111K	0.68%	45
2024 Q4	$4.16M	Sell	27,577 -628	-2%	-$97.7K	0.64%	45
2024 Q3	$4.38M	Sell	28,205 -10	-0%	-$1.49K	0.65%	43
2024 Q2	$3.86M	Hold	28,215	–	–	0.61%	45
2024 Q1	$3.76M	Sell	28,215 -85	-0.3%	-$11K	0.57%	50
2023 Q4	$3.9M	Sell	28,300 -75	-0.3%	-$9.86K	0.63%	47
2023 Q3	$3.46M	Sell	28,375 -90	-0.3%	-$12K	0.59%	50
2023 Q2	$4M	Hold	28,465	–	–	0.66%	46
2023 Q1	$4.03M	Sell	28,465 -2,400	-8%	-$343K	0.7%	43
2022 Q4	$4.83M	Sell	30,865 -232	-0.7%	-$33.3K	0.83%	39
2022 Q3	$3.81M	Sell	31,097 -213	-0.7%	-$28.1K	0.74%	40
2022 Q2	$4.16M	Sell	31,310 -15	-0%	-$2.04K	0.74%	41
2022 Q1	$4.29M	Sell	31,325 -2,655	-8%	-$370K	0.68%	43
2021 Q4	$5.88M	Sell	33,980 -1,800	-5%	-$274K	0.91%	33
2021 Q3	$5.2M	Sell	35,780 -1,100	-3%	-$161K	0.88%	38
2021 Q2	$4.87M	Sell	36,880 -60	-0.2%	-$7.86K	0.81%	41
2021 Q1	$4.74M	Sell	36,940 -25	-0.1%	-$3.08K	0.82%	39
2020 Q4	$4.41M	Sell	36,965 -30	-0.1%	-$3.66K	0.82%	39
2020 Q3	$4.24M	Sell	36,995 -50	-0.1%	-$5.91K	0.89%	35
2020 Q2	$4.22M	Hold	37,045	–	–	0.93%	34
2020 Q1	$2.98M	Sell	37,045 -1,000	-3%	-$104K	0.74%	41
2019 Q4	$4.06M	Hold	38,045	–	–	0.76%	45
2019 Q3	$4.07M	Sell	38,045 -1,025	-3%	-$105K	0.82%	43
2019 Q2	$3.98M	Sell	39,070 -200	-0.5%	-$19.2K	0.79%	44
2019 Q1	$3.53M	Hold	39,270	–	–	0.73%	45
2018 Q4	$3.27M	Sell	39,270 -150	-0.4%	-$14.1K	0.73%	45
2018 Q3	$4.25M	Sell	39,420 -1,000	-2%	-$110K	0.8%	42
2018 Q2	$4.44M	Hold	40,420	–	–	0.89%	41
2018 Q1	$4.05M	Sell	40,420 -2,175	-5%	-$223K	0.81%	44
2017 Q4	$4.2M	Hold	42,595	–	–	0.81%	45
2017 Q3	$3.99M	Sell	42,595 -50	-0.1%	-$5.31K	0.81%	46
2017 Q2	$4.74M	Sell	42,645 -3,200	-7%	-$338K	0.97%	38
2017 Q1	$4.5M	Sell	45,845 -8,150	-15%	-$777K	0.94%	40
2016 Q4	$4.96M	Sell	53,995 -15,535	-22%	-$1.34M	1.08%	30
2016 Q3	$5.88M	Sell	69,530 -425	-0.6%	-$35.7K	1.32%	21
2016 Q2	$5.7M	Hold	69,955	–	–	1.3%	21
2016 Q1	$5M	Sell	69,955 -315	-0.4%	-$21.1K	1.18%	28
2015 Q4	$5M	Sell	70,270 -2,550	-4%	-$171K	1.13%	34
2015 Q3	$4.48M	Sell	72,820 -150	-0.2%	-$10.5K	1.05%	37
2015 Q2	$5.29M	Sell	72,970 -50	-0.1%	-$3.69K	1.1%	36
2015 Q1	$5.61M	Sell	73,020 -1,780	-2%	-$127K	1.13%	33
2014 Q4	$5.02M	Sell	74,800 -4,150	-5%	-$262K	1%	39
2014 Q3	$4.79M	Sell	78,950 -50	-0.1%	-$3.08K	1%	39
2014 Q2	$4.64M	Sell	79,000 -1,350	-2%	-$79.1K	0.95%	39
2014 Q1	$4.65M	Hold	80,350	–	–	0.99%	39
2013 Q4	$4.3M	Buy	80,350 +19,300	+32%	+$1.14M	0.9%	41
2013 Q3	$3.77M	Buy	61,050 +50,500	+479%	+$3.02M	0.87%	44
2013 Q2	$640K	Buy	+10,550	New	+$628K	0.15%	100

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Auxier Asset Management's DGX Position: Q1 2026 in Review

Auxier Asset Management reduced its Quest Diagnostics (DGX) stake by 1.8% in Q1 2026, selling an estimated $89.4K and leaving 25,451 shares worth $4.99M. The position accounts for 0.72% of the portfolio, ranked #43.

Auxier Asset Management first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.88M in Q3 2016. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Auxier Asset Management held 25,451 shares of Quest Diagnostics worth $4.99M as of Q1 2026.
Auxier Asset Management sold 460 Quest Diagnostics shares in Q1 2026, an estimated $89.4K.
Quest Diagnostics made up 0.72% of Auxier Asset Management's portfolio in Q1 2026, its #43 holding.
Auxier Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
Auxier Asset Management's Quest Diagnostics position peaked at $5.88M in Q3 2016.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Auxier Asset Management's 13F filing for Q1 2026, filed 14 May 2026.